Anti-obesity drugs

1 paper

Funders: Novo Nordisk Foundation and 1 more

Funding

2 grants since 2020

VetenskapsrådetSEK 2.4mNovo Nordisk FoundationDKK 1.1m

AI-ACELLERATED STRUCTURE-BASED DISCOVERY OF Y4 RECEPTOR ANTAGONISTS AS GLP-1 AND AMYLIN RECEPTOR AGONIST-ENHANCING ANTI-OBESITY DRUGS
Novo Nordisk FoundationUniversity of CopenhagenDKK 1.1m2024
The mechanism of clinically used anti-obesity drugs targeting glucagon-like peptide 1 (GLP-1) receptor; an unexpected non-synaptic brain signalling
VetenskapsrådetUniversity of GothenburgSEK 2.4m2020–2022

Latest

Journal of Bone and Mineral Research3 Oct

Effects of weight-loss interventions on bone health in people living with obesity